NCT07285694
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07285694
Title AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Arsenal Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California, San Francisco San Francisco California 94143 United States Details
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) Aurora Colorado 80045 United States Details
University of Iowa and Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
The University of Kansas Cancer Center Fairway Kansas 66205 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Perlmutter Cancer Center - NYU Langone Health New York New York 10016 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field